TotalMarketCap

Axsome Therapeutics

AXSMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$9.132 B

$174.34 -1.55%

Close of 7 Oct 2026

As of 7 Oct 2026, Axsome Therapeutics (AXSM) has a market capitalization of $9.13B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$638.5M

#1784 by revenue

Earnings

-$183.2M

Loss-making

Shares outstanding

52,380,818

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #32Biomarin PharmaceuticalBMRN$10.9B
  2. #33Dr Reddys LaboratoriesRDY$10.4B
  3. #34Axsome TherapeuticsAXSM$9.13B
  4. #35Protagonist TherapeuticsPTGX$8.97B
  5. #36Arrowhead PharmaceuticalsARWR$8.69B

What if Axsome Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.8T

$549,617.88

Per share 3,153× higher

Bitcoin $1.67T

$31,886.63

Per share 183× higher

Nvidia $5.77T

$110,072.43

Per share 631× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Axsome Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.